Published in Front Physiol on May 03, 2012
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol (2013) 2.61
Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res (2012) 2.18
Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol (2012) 1.49
Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol (2013) 1.32
Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front Immunol (2014) 1.24
EVpedia: a community web portal for extracellular vesicles research. Bioinformatics (2014) 1.21
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles (2015) 1.11
Emerging roles of extracellular vesicles in the nervous system. J Neurosci (2014) 1.09
The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. Front Genet (2013) 1.08
Extracellular vesicles as mediators of neuron-glia communication. Front Cell Neurosci (2013) 1.08
Acceleration of α-synuclein aggregation by exosomes. J Biol Chem (2014) 1.04
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Brain (2015) 1.03
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry (2014) 1.03
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo. Mol Brain (2013) 1.01
The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy (2015) 1.00
Secretion of microvesicular miRNAs in cellular and organismal aging. Exp Gerontol (2012) 0.98
Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos Trans R Soc Lond B Biol Sci (2014) 0.98
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation. Front Cell Neurosci (2015) 0.97
The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J Biol Chem (2014) 0.95
Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons. J Extracell Vesicles (2014) 0.94
Exosomes-associated neurodegeneration and progression of Parkinson's disease. Am J Neurodegener Dis (2012) 0.92
Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis. Nat Commun (2013) 0.92
Extracellular RNA mediates and marks cancer progression. Semin Cancer Biol (2014) 0.90
Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation. Acta Neuropathol (2015) 0.90
Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. ACS Chem Neurosci (2013) 0.89
Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep (2016) 0.88
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden. J Alzheimers Dis (2015) 0.87
Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer. Proteomes (2013) 0.86
Exosomes function in cell-cell communication during brain circuit development. Curr Opin Neurobiol (2013) 0.86
Extracellular vesicles in Alzheimer's disease: friends or foes? Focus on aβ-vesicle interaction. Int J Mol Sci (2015) 0.85
Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease. Int J Mol Sci (2016) 0.84
Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front Mol Neurosci (2015) 0.84
Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles. Int J Mol Sci (2016) 0.84
Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD. Cell Rep (2016) 0.84
The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases. Front Physiol (2015) 0.83
Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles. J Extracell Vesicles (2015) 0.83
Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networks. Philos Trans R Soc Lond B Biol Sci (2014) 0.83
Inflammatory Response in the CNS: Friend or Foe? Mol Neurobiol (2016) 0.83
Microparticles: a new perspective in central nervous system disorders. Biomed Res Int (2014) 0.82
Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner. J Biol Chem (2016) 0.82
Exosomes: The Messengers of Health and Disease. Curr Neuropharmacol (2016) 0.80
Extracellular vesicles of the blood-brain barrier. Tissue Barriers (2015) 0.80
Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions. J Biol Chem (2016) 0.80
Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging. Ann Clin Transl Neurol (2016) 0.79
Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture. Cell Mol Neurobiol (2016) 0.78
Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders. Front Neurosci (2016) 0.78
Exosomes as Novel Regulators of Adult Neurogenic Niches. Front Cell Neurosci (2016) 0.78
Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling. Mol Brain (2016) 0.78
Release of bulk cell free DNA during physical exercise occurs independent of extracellular vesicles. Eur J Appl Physiol (2015) 0.78
In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes. Anal Cell Pathol (Amst) (2016) 0.77
RNA in extracellular vesicles. Wiley Interdiscip Rev RNA (2017) 0.77
Exosome-Based Delivery of miR-124 in a Huntington's Disease Model. J Mov Disord (2017) 0.77
Extracellular membrane microvesicles and nanotubes in the brain: understanding their nature, their function in cell-to-cell communication, their role in transcellular spreading of pathological agents and their therapeutic potential. Front Physiol (2013) 0.77
The effect of aging on brain barriers and the consequences for Alzheimer's disease development. Mamm Genome (2016) 0.77
Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes. Front Neurosci (2017) 0.76
Study of Exosomes Shed New Light on Physiology of Amyloidogenesis. Cell Mol Neurobiol (2016) 0.76
Horizontal Transmission of Cytosolic Sup35 Prions by Extracellular Vesicles. MBio (2016) 0.76
Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury. Mol Cell Proteomics (2016) 0.76
Myeloid Extracellular Vesicles: Messengers from the Demented Brain. Front Immunol (2016) 0.76
Information handling by the brain: proposal of a new "paradigm" involving the roamer type of volume transmission and the tunneling nanotube type of wiring transmission. J Neural Transm (Vienna) (2014) 0.76
Exosomes as the source of biomarkers of metabolic diseases. Ann Pediatr Endocrinol Metab (2016) 0.76
Milk exosomes: beyond dietary microRNAs. Genes Nutr (2017) 0.75
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther (2016) 0.75
Exosomes, an Unmasked Culprit in Neurodegenerative Diseases. Front Neurosci (2017) 0.75
Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology. Mol Cell Neurosci (2016) 0.75
Progress in Exosome Isolation Techniques. Theranostics (2017) 0.75
Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery. RNA Biol (2016) 0.75
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Promoting neuronal regeneration using extracellular vesicles loaded with superparamagnetic iron oxide nanoparticles. Neural Regen Res (2016) 0.75
Prenatal transmission of scrapie in sheep and goats: A case study for veterinary public health. Open Vet J (2016) 0.75
Exosomes: From Garbage Bins to Promising Therapeutic Targets. Int J Mol Sci (2017) 0.75
Insulin resistance in Alzheimer's disease. Transl Res (2016) 0.75
Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein. Front Neurosci (2017) 0.75
Exosomes: Origins and Therapeutic Potential for Neurodegenerative Disease. Front Neurosci (2017) 0.75
Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Mutant huntingtin inhibits αB-crystallin expression and impairs exosome secretion from astrocytes. J Neurosci (2017) 0.75
Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of α-synuclein via exosome. PLoS One (2017) 0.75
Extracellular Vesicles, Tunneling Nanotubes, and Cellular Interplay: Synergies and Missing Links. Front Mol Biosci (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 13.99
miRNAs, cancer, and stem cell division. Cell (2005) 12.15
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 9.68
Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science (2008) 9.42
A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 8.33
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 8.21
Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem (2010) 8.09
Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 6.96
Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol (2001) 6.96
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A (2009) 6.87
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med (2008) 6.86
Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 6.72
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26
Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 6.24
Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol (2009) 6.03
Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A (2007) 5.94
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood (2011) 5.82
Exosomes: a common pathway for a specialized function. J Biochem (2006) 5.79
Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem (2009) 5.76
The neuronal microRNA system. Nat Rev Neurosci (2006) 5.38
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24
Cells release prions in association with exosomes. Proc Natl Acad Sci U S A (2004) 5.17
Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer (2009) 5.11
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev (2009) 5.04
Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem (1987) 4.99
Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron (2011) 4.74
Exosome function: from tumor immunology to pathogen biology. Traffic (2008) 4.50
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem (2003) 4.14
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07
Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A (2006) 3.98
Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science (1993) 3.95
Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci (2010) 3.81
Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods (2007) 3.74
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology (2010) 3.70
Engineering targeted viral vectors for gene therapy. Nat Rev Genet (2007) 3.69
Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood (2004) 3.68
Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem (2011) 3.57
Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol (2009) 3.55
Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol (2009) 3.55
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest (2011) 3.53
Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One (2010) 3.50
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A (2009) 3.47
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature (2010) 3.41
Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA (2010) 3.40
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23
Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis (2009) 3.11
Exosomes are released by cultured cortical neurones. Mol Cell Neurosci (2006) 3.07
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J (2006) 2.96
Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci (2009) 2.96
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem (2011) 2.86
Lipid raft-associated protein sorting in exosomes. Blood (2003) 2.76
Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett (2009) 2.75
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev (1997) 2.72
Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog (2010) 2.63
Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A (2009) 2.61
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer (2011) 2.56
Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods (2008) 2.56
Transfer of scrapie prion infectivity by cell contact in culture. Curr Biol (2002) 2.54
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci (2000) 2.41
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis (2011) 2.32
Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol (2007) 2.31
Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol (2007) 2.30
A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther (2010) 2.29
Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem (1993) 2.18
Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci (2010) 2.17
Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J (2002) 2.16
Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem (2007) 1.99
Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol (2005) 1.98
A miRNA signature of prion induced neurodegeneration. PLoS One (2008) 1.96
Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem (2010) 1.94
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet (2011) 1.92
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis (2008) 1.89
MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem (2008) 1.86
Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci (2005) 1.85
Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One (2008) 1.84
Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet (2010) 1.83
Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem (2010) 1.80
Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation. J Cell Sci (1997) 1.80
Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid. J Mol Biol (2000) 1.77
miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res (2012) 1.76
Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer (2011) 1.76
Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol (2010) 1.71
Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol (2010) 1.67
Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem (2009) 1.67
Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry (2007) 1.62
Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol (2006) 1.60
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J (2002) 2.98
Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science (2004) 2.82
Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell (2013) 2.76
Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res (2012) 2.18
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet (2006) 1.97
PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. Cell Res (2009) 1.64
Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J (2008) 1.52
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J (2005) 1.51
Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci (2005) 1.51
The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J (2007) 1.50
Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (2014) 1.48
Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol (2002) 1.46
MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol (2013) 1.45
Molecular and clinical classification of human prion disease. Br Med Bull (2003) 1.45
Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A (2008) 1.37
Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Vet Immunol Immunopathol (2008) 1.36
Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem (2006) 1.29
Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. J Biol Chem (2010) 1.28
ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem (2008) 1.20
Prion-infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J (2012) 1.19
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein. Biochemistry (2008) 1.18
A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans R Soc Lond B Biol Sci (2008) 1.10
Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation. Free Radic Biol Med (2009) 1.09
Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. J Biol Chem (2007) 1.08
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem (2006) 1.08
The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. Front Genet (2013) 1.08
Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. Int J Biochem Cell Biol (2008) 1.06
Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol Cell Proteomics (2013) 1.04
Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Res Bull (2005) 1.03
Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. J Biol Chem (2008) 1.01
Conformation sensors that distinguish monomeric proteins from oligomers in live cells. Chem Biol (2010) 1.00
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. Biochem Biophys Res Commun (2009) 0.99
Prion protein glycosylation. J Neurochem (2005) 0.99
Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem Sci (2006) 0.98
A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's disease. Proteomics (2010) 0.96
Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. J Mol Biol (2009) 0.96
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. J Exp Med (2012) 0.96
Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein. J Neurosci Res (2003) 0.95
Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos. RNA Biol (2015) 0.93
Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. J Alzheimers Dis (2009) 0.91
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection. J Neuropathol Exp Neurol (2009) 0.90
Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Neurobiol Dis (2011) 0.88
Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol (2010) 0.88
Intracellular itinerary of internalised β-secretase, BACE1, and its potential impact on β-amyloid peptide biogenesis. Traffic (2013) 0.87
Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain. J Biol Chem (2010) 0.86
Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity. J Biol Chem (2010) 0.83
Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. Biochem J (2007) 0.83
Arl5b is a Golgi-localised small G protein involved in the regulation of retrograde transport. Exp Cell Res (2012) 0.82
A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity. J Biol Chem (2013) 0.82
Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein. PLoS One (2010) 0.82
Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control. Neurobiol Dis (2005) 0.82
Both IFN-γ and IL-17 are required for the development of severe autoimmune gastritis. Eur J Immunol (2012) 0.82
Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP. Immunol Cell Biol (2005) 0.81
Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide. Int J Biochem Cell Biol (2008) 0.81
The brain to gut pathway: a possible route of prion transmission. Gut (2010) 0.81
Prion infection impairs cholesterol metabolism in neuronal cells. J Biol Chem (2013) 0.81
Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell. J Biol Chem (2014) 0.81
SERF protein is a direct modifier of amyloid fiber assembly. Cell Rep (2012) 0.81
Neurotoxic species in prion disease: a role for PrP isoforms? J Neurochem (2007) 0.80
Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine. Auton Neurosci (2008) 0.80
Polyglutamine aggregation in Huntington and related diseases. Adv Exp Med Biol (2012) 0.80
High density lipoproteins bind Abeta and apolipoprotein C-II amyloid fibrils. J Lipid Res (2006) 0.80
Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. Mol Neurodegener (2012) 0.80
Manganese chelation therapy extends survival in a mouse model of M1000 prion disease. J Neurochem (2010) 0.80
Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible? Eur Biophys J (2007) 0.79
APP involvement in retinogenesis of mice. Acta Neuropathol (2010) 0.79
Modulation of amyloid precursor protein processing by synthetic ceramide analogues. Biochim Biophys Acta (2010) 0.79
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function. Biochem J (2010) 0.78
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. J Virol (2013) 0.78
High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease. Curr Alzheimer Res (2016) 0.76
Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation. PLoS One (2013) 0.76
Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes. Methods Mol Biol (2008) 0.76
Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity. J Alzheimers Dis (2011) 0.76
Analysis of PrP conformation using circular dichroism. Methods Mol Biol (2008) 0.76
Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues. Clin Sci (Lond) (2012) 0.75
Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology (2011) 0.75
The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. J Biol Chem (2012) 0.75
C-terminal peptides modelling constitutive PrPC processing demonstrate ameliorated toxicity predisposition consequent to α-cleavage. Biochem J (2014) 0.75
An Escherichia coli cell-free system for recombinant protein synthesis on a milligram scale. Methods Mol Biol (2011) 0.75
Molecular typing of PrPres in human sporadic CJD brain tissue. Methods Mol Biol (2008) 0.75
Not a day without microRNA. Curr Opin Lipidol (2015) 0.75